Characterized by a surplus of whole-body adiposity, obesity is strongly associated with the
prognosis of atherosclerosis, a hallmark of coronary artery disease (CAD) and the major …

Background Atherosclerosis is a deadly consequence of cardiovascular disease and has
very high mortality rate worldwide. The epigenetic modifications can regulate the …

Osteoarthritis (OA) is a complex condition that involves both apoptosis and senescence and
currently cannot be cured. Fibroblast growth factor 21 (FGF21), known for its role as a potent …

Cardiovascular and metabolic disease (CVMD) is becoming increasingly prevalent in
developed and developing countries with high morbidity and mortality. In recent years …

Abstract Fibroblast growth factor 21 (FGF21) is an endocrine cytokine that targets
inflammation and atherosclerosis (AS). However, the underlying molecular mechanisms of …

Fibroblast growth factor 21 (FGF21), a member of fibroblast growth factor family, is a
hormone-like growth factor that is synthesized mainly in the liver and adipose tissue. FGF21 …

Fibroblast growth factor 21 (FGF21), a known risk factor for atherosclerosis, is readily
regulated by exercise, and it can inhibit NOD-like receptor protein 3 (NLRP3)-mediated …

Random-pattern skin flap is commonly used for surgical tissue reconstruction due to its ease
and lack of axial vascular limitation. However, ischemic necrosis is a common complication …

Abstract Fibroblast growth factor 21 (FGF21) acts as an anti‐atherosclerotic agent. However,
the specific mechanisms governing this regulatory activity are unclear. Autophagy is a highly …

The prevalence of NAFLD (non-alcoholic fatty liver disease) is a rapidly increasing problem,
affecting a huge population around the globe. However, CVDs (cardiovascular diseases) …